source
- BioNTech appoints Sobi head Guido Oelkers as new CEO to steer oncology shiftBioNTech announced that Guido Oelkers, who has led the rare‑disease focused Swedish company Sobi since 2017, will become its next chief executive officer. Oelkers is slated to take over the role b…
- BlossomHill eyes $112M IPO harvest to bankroll potential Tagrisso challengerBlossomHill Therapeutics plans to raise $111.7 million to fund the clinical journey of its potential challenger to Tagrisso.Fierce Biotech · 8h ago↗ source
- After 5-month wait, BioNTech announces Sobi CEO will take on top job at mRNA company